Glenmark Pharmaceuticals Limited (GLENMARK.BO) currently reports a inventory of $34B as of March 2026. That compares with $33B in the prior-year period — up 4.6% year over year. Use the charts on this page to explore Glenmark Pharmaceuticals Limited's inventory history and peer comparisons.

Glenmark Pharmaceuticals Limited's inventory increased from $33B to $34B — a 4.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Glenmark Pharmaceuticals Limited reported $34B in inventory as of March 2026. That compares with $33B in the prior-year period — up 4.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $34B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Glenmark Pharmaceuticals Limited, and consider following GLENMARK.BO for alerts when major investors trade the stock.